Capstone’s State of Midmarket M&A Q1-Q3 2014 Update indicates a steady growth in midmarket mergers and acquisitions. We surveyed midmarket executives from multiple industries to learn how the first nine months of 2014 matched expectations from 2013, and to indicate any new trends in midmarket M&A. The survey was conducted in October 2014, and follows a …
Tag: Capstone
M&A Update: 3Q 2014
In the first nine months of 2014, US transactions made up 51% of global mergers and acquisitions indicating confidence in the strength of the US economy. In Europe, cash-stuffed German companies looked to international markets, especially the US, to drive growth. Recent deals include Siemens acquisition of Dresser Rand for $7.6 billion, Merck of Germany’s …
The Dangers of Getting Swept Away In the Excitement of a Deal
“The danger with a mergers-and-acquisitions boom is that chief executives could allow themselves to get carried away by the thrill of the hunt, reducing their focus on internal investment projects that might have a better chance of bearing fruit,” says the New York Time’s Dealbook column. M&A activity has reached record highs and shows no …
Valeant Seeks More Acquisitions
Valeant Pharmaceuticals International is determined to grow through acquisitions. Already actively pursuing a deal with Allergan, the maker of Botox, Valeant is reportedly seeking another contact lens company. CEO Michael Pearson said the company “will not be content to remain the No. 4 global player in the contact lens industry.” Valeant has a history of …
M&A Update: 1H 2014
M&A activity was on the rise in the first six months of 2014. Global M&A increased 73 percent to $1.77 trillion and Midmarket M&A increased 18 percent to $399.4 billion. Check out our infographic for a snapshot on Global Mergers and Acquisitions in 1H 2014. Click on the image for a closer look. Feature Photo …
M&A – The Route to Success?
The polyolefins industry, like so many others, is evolving significantly. Growth in emerging markets and Asia has skyrocketed while European and North American markets have matured. Last week I was invited to speak at the Future of Polyolefins Conference 2014 in Dusseldorf, Germany, where top executives from key industry players such as Borealis AG and …
Pharmaceuticals Refocus and Consolidate
Pharmaceutical companies are using acquisition to become “pointy,” or more focused. Two recent examples are Bayer and Merck. Bayer is focusing on over the counter medications by acquiring Merck’s consumer care business for $14.2 billion. On the other hand, Merck has become more streamlined through divestment. As I’ve mentioned before, although divestment means becoming smaller, …
Capstone Builds Michelman-Maruyoshi Chemical Joint Venture
January 13, 2014 (McLean, VA) – Capstone Strategic, Inc., a leading management consulting firm specializing in strategic growth, announced today that Michelman and Maruyoshi Chemical have entered into a joint venture, Maruyoshi Michelman Co. Ltd. Michelman is a global developer of water-based coatings headquartered in Cincinnati, OH. Maruyoshi is a specialty waterborne polyolefin emulsions and chemical …
Due Diligence: The Three Buckets of Critical Information
In performing due diligence, I recommend you look not only for risks but also for opportunities. That’s how I approach due diligence for our Capstone clients. As we examine the seller’s operations and books, we place every new discovery in one of three color-coded “buckets:” Red Bucket: Deal Changers. This is information that materially alters …
